Look at what cancer biotechs have been doing so far this year, it's white hot and getting hotter! 2014 and beyond is all about cancer immunotherapy, and PPHM is square in the middle of this. It's safe to say that we have now begun to build share price momentum since the announcement of Fast Track approval. This now validates BAVI and will lead to securing a BP, maybe already done for that matter and may be announced Monday the day before the JPMorgan Health Conference starts on Tuesday. Now that would be freaking awesome. All I know it's finally starting to get really interesting here. Things nice real quick in biotech land and I'm glad I'm part of it with my investment in a soon to be small pharma company known as Peregrine Pharmaceuticals that will bring astronomical value to their shareholders.
News 
Market Data 
Discover 
